PharmiWeb.com - Global Pharma News & Resources
02-Apr-2021

Worldwide Analysis On Dextrose Injection Market Size and Trends by 2021 – 2027

SEATTLE, April 02, 2021, (PHARMIWEB) — Global Dextrose Injection Market

Dextrose is a simple sugar made from corn, and is highly similar to glucose, as the two possess identical chemical properties. Dextrose plays a vital role in providing energy to body cells. Dextrose Injection is a non-pyrogenic and sterile solution for caloric supply and fluid replenishment. The route of administration of the dextrose injection is intravenous, i.e. into the vein. Its dosage depends upon an individual’s body weight, age, as well as clinical condition. Only 5% of dextrose, combined with water, is injected into the vein to replace the lost fluids and provide carbohydrates to the body. However, dextrose, in this amount, can also be used to treat hypoglycemia (low blood sugar), insulin shock, and dehydration (fluid loss). A dextrose solution, along with amino acids and fats, provides nutrition the body, which is commonly termed as total parental nutrition. Moreover, dextrose solution (50%) is generally administered to a person suffering from hyperkalemia – a condition in which potassium levels in the body increase significantly.

Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/1835

Global Dextrose Injection Market Overview

A significant growth driver for the global dextrose injection market is the robust pipeline of drugs currently undergoing clinical trials. For instance, in 2017, Tri Service General Hospital concluded its 5% dextrose injection Phase 1 clinical trials. In the same year, the Hospital was reported to have completed its 10% dextrose injection Phase 2 clinical trials. For the record, 10% dextrose injection is used to treat the Carpal tunnel syndrome.

Escalating number of novel product launches by key market players is expected to further drive the global market growth. For instance, in 2018, SteriMAx Inc., engaged in the production, development, marketing, and distribution of essential hospital and retail pharmacy products. It subsequently launched the new drug, Bupivacaine Hydrochloride, in 8.25% dextrose injection indicated for spinal anesthesia.

Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://bit.ly/3drlf9M

New drug approvals are foreseen to boost the global dextrose injection market growth during the forecast period. For instance, in 2017, Clindamycin in dextrose injection (D5W) made by Water Street Healthcare Partners, was approved by the U.S. FDA. Clindamycin in dextrose injection (D5W) is used to treat bacterial infections, such as Pneumonia, by inhibiting bacteria growth in the body.

Furthermore, rising prevalence of diseases, such as hypoglycemia, would increase the demand for dextrose injection, which in turn, would fuel market growth. According to a survey conducted by the Center for Disease Prevention and Control (CDC), over 1.5 million people in the U.S. were diagnosed with hypoglycemia in 2016. However, the side effects caused by dextrose injection, such as fever, infection and blood clot formation at the site of injection, are pivotal factors restraining the growth of the global dextrose injection market.

Global Dextrose Injection Market – Regional Analysis

The North America dextrose injection market is expected to hold a dominant position over the forecast timeframe, due to the presence of major players in the region and a robust pipeline of products. For instance, in 2016, Chisel Peak Medical Clinic, completed phase 2 clinical trials of its 20% dextrose injection indicated for treatment of temporomandibular dysfunction. Temporomandibular dysfunction is a type of temporomandibular disorder that causes pain in jaw joint and also in the muscles that control the jaw movement. Increasing number of launches pertaining to novel dextrose injection products is expected to fuel regional market growth. For instance, in 2016, Baxter International Inc. launched ready to use version of vancomycin injection. Vancomycin injection treats infections caused by strains of methicillin-resistant staphylococci.

*The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.

Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1835

The Asia Pacific market is poised to witness substantial growth in the near future, due to various sports initiatives taken by governments of various countries in the region. India has various schemes for sports, such as ‘Khelo India’, National Sports Development Fund Scheme for promotion of sports among individuals suffering from disabilities. According to the Khelo India program, up to 1000 students will be selected annually, and will be offered a sponsorship of 5 lakhs. Such huge participation in sports is expected to boost the growth of the regional market. Athletes use Dextrose injection to treat a variety of ligament, muscle, tendon, and joint pains. Approval of new drugs is expected to fuel growth of dextrose injection market in Asia Pacific. For instance, in 2016, Aurobindo Pharmaceuticals Ltd. received the U.S. FDA approval for Levofloxacin Injection in dextrose injection, which is indicated for the treatment of bacterial infections in adults.

Global Dextrose Injection Market – Key Competitors

The most prominent players operating in the global dextrose injection market include Pfizer Inc., Amphastar Pharmaceuticals Inc., Shangai Haixin group Co. Ltd., Seqirus GmbH, Baxter International Inc., Shandong Qidu Pharmaceutical, Sanctus drugs and pharmaceuticals Pvt., Hospira Inc., B Braun Medical Ltd., Aurobindo Pharmaceuticals Ltd., and SteriMAx Inc.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/market-insight/dextrose-injection-market-1835

Global Dextrose Injection Market Taxonomy

By Product type:

  • 5% Dextrose Injection
  • 10% Dextrose Injection
  • 50% Dextrose Injection
  • 70% dextrose Injection
  • Others

By Applications:

  • First-aid Treatment
  • Sports
  • Trophotherapy
  • Others

By Distribution Channel:

  • Hospitals/clinics
  • Online pharmacies
  • Retail pharmacies

By Region:

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East
  • Africa

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/dextrose-injection-market-3496

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Highlights
    • Regulatory Scenario
    • PEST Analysis
    • Porter’s Analysis
    • Mergers and Acquisition
    • Product Launches/Approvals
  4. Global Dextrose Injection Market – Impact of Coronavirus (Covid-19) Pandemic
    • Economic Impact
    • Supply Chain Analysis
    • Government Measures to Combat COVID-19
  5. Global Dextrose Injection Market, By Product Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • 5% Dextrose Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • 10% Dextrose Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • 50% Dextrose Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • 70% Dextrose Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Dextrose Injection Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • First-aid Treatment
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Sports
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Trophotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Dextrose Injection Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Global Dextrose Injection Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact
About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 24-Oct-2021